secwatch.observer — SEC 8-K summary
======================================

Issuer:     OS Therapies Inc (OSTX)
CIK:        0001795091
Form:       8-K/A
Filed at:   2026-07-07T13:18:33+00:00
Accession:  0001213900-26-075781
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 9.01
LLM model:  deepseek-v4-flash:cloud@v2

OS Therapies amends private placement terms with Leonite; dilutive adjustment delayed to Sept 30, 2026
--------------------------------------------------------------------------------

- Side letter modifies anti-dilution provisions in $10M convertible note and warrant.
- Dilutive issuance adjustments under Note and Warrant will not become effective until September 30, 2026.
- Carve-out for offerings of at least $5M gross proceeds now requires single closing, not aggregated tranches.
- Agreement dated June 30, 2026 between OS Therapies and Leonite Fund I, LP.
- No other changes to transaction documents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026075781/0001213900-26-075781-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1795091/000121390026075781/ea0297249-8ka1_ostherapies.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-075781

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer